ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	26 October 2021
Main ID:	NCT03637023
Date of registration:	10/08/2018
Prospective Registration:	Yes
Primary sponsor:	Farzin Hajebrahimi, PT, MSc
Public title:	Virtual Reality for Parkinson's Disease
Scientific title:	Clinical and Rest-fMRI Effects of Virtual Reality Practice on Motor and Cognitive Symptoms in Parkinson's Disease, a Randomized Control Trial
Date of first enrolment:	August 18, 2018
Target sample size:	30
Recruitment status:	Terminated
URL:	https://clinicaltrials.gov/show/NCT03637023
Study type:	Interventional
Study design:	Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Phase:	N/A

Countries of recruitment
Turkey

Contacts

Name:	Farzin Hajebrahimi
Address:
Telephone:
Email:
Affiliation:	Medipol University

Name:	Lutfu Hanoglu, Professor
Address:
Telephone:
Email:
Affiliation:	Medipol University

Key inclusion & exclusion criteria

Inclusion Criteria:

- To be 50 years old and older

- Clinical diagnosis of PD within the -framework of Brain Bank criteria

- Getting a stable antiparkinsonian medication at least for the last 1 month (or the
treatment has not changed)

Exclusion Criteria:

- Having a story of unstable medical condition

- History of head trauma, stroke, or exposure to toxic substances

- Implying Parkinson plus syndromes in neurological examinations; pyramidal, cerebellar
examination findings, gaze paresis, autonomic dysfunction

- Being diagnosed with Dementia

Age minimum: 50 Years
Age maximum: 85 Years
Gender: All

Health Condition(s) or Problem(s) studied

Virtual Reality Therapy

Functional Magnetic Resonance Imaging

Parkinson Disease

Intervention(s)

Behavioral: Exercise Therapy

Behavioral: Virtual Reality

Primary Outcome(s)

Motor Level [Time Frame: Change from Baseline at 4 weeks.]

Cognitive Level [Time Frame: Change from Baseline at 4 weeks.]

Neuroplasticity [Time Frame: Change from Baseline at 4 weeks.]

Secondary Outcome(s)

Balance Confidence [Time Frame: Change from Baseline at 4 weeks.]

Balance [Time Frame: Change from Baseline at 4 weeks.]

Cognitive Assessment [Time Frame: Change from Baseline at 4 weeks.]

Quality of Life in patients with Parkinson's Disease [Time Frame: Change from Baseline at 4 weeks.]

Depression [Time Frame: Change from Baseline at 4 weeks.]

Mobility [Time Frame: Change from Baseline at 4 weeks.]

Functional Capacity [Time Frame: Change from Baseline at 4 weeks.]

Secondary ID(s)

PD-VR-2018

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.